Targeting NF-κB and induction of apoptosis by novel NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells

被引：15

作者：

Kimura, Noriko

Miyakawa, Yoshitaka ^{[1
]}

Kohmura, Kanoko

Umezawa, Kazuo

Ikeda, Yasuo

Kizaki, Masahiro

机构：

[1] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo 1608582, Japan

[2] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kanagawa, Japan

来源：

LEUKEMIA RESEARCH | 2007年 / 31卷 / 11期

关键词：

NF-kappa B; Burkitt lymphoma; apoptosis; caspase-3; IAP;

D O I：

10.1016/j.leukres.2007.02.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A new NF-kappa B inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), inhibited proliferation and induced apoptosis in human Burkitt lymphoma, HS-Sultan and Daudi cell lines. The activation of caspase-3 and the cleavage of caspase substrate PARP were observed after treatment with DHMEQ. The induction of apoptosis by DHMEQ was prevented by the pretreatment of Burkitt lymphoma cells with pan-caspase inhibitor, z-VAD-FMK. The expression of anti-apoptotic factors such as IAP-1 and XIAP was suppressed by DHMEQ. Phosphorylation of ERK and INK was induced by DHMEQ. In conclusion, these results demonstrate that NF-kappa B might be an ideal target to develop for new anti-cancer drugs for Burkitt lymphoma. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：1529 / 1535

页数：7

共 50 条

[41] Topical application with DHMEQ, a novel NF-κB inhibitor, improves atopic dermatitis in murine model
Abe, R.
Hamasaka, A.
Yoshioka, N.
Kishino, S.
Umezawa, K.
Ozaki, M.
Todo, S.
Shimizu, H.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S48 - S48
[42] NF-κB and apoptosis in mammary epithelial cells
Clarkson, RWE
Watson, CJ
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (02) : 165 - 175
[43] Identification of the RelA domain responsible for action of a new NF-κB inhibitor DHMEQ
Watanabe, Mariko
Nakashima, Makoto
Togano, Tomiteru
Higashihara, Masaaki
Watanabe, Toshiki
Umezawa, Kazuo
Horie, Ryouichi
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 376 (02) : 310 - 314
[44] Erratum: To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Jérôme Kucharczak
Matthew J Simmons
Yongjun Fan
Céline Gélinas
Oncogene, 2004, 23 : 8858 - 8858
[45] Fas regulates the apoptosis and migration of trophoblast cells by targeting NF-κB
Lan, Ruihong
Yang, Yang
Song, Jie
Wang, Ling
Gong, Humin
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
[46] Inhibition of active HIV-1 replication by NF-κB inhibitor DHMEQ
Miyake, Ariko
Ishida, Takaomi
Yamagishi, Makoto
Hara, Takuma
Umezawa, Kazuo
Watanabe, Toshiki
Horie, Ryouichi
MICROBES AND INFECTION, 2010, 12 (05) : 400 - 408
[47] Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ
Ma, Jun
Zhang, Yuyang
Sugai, Takeshi
Kubota, Tetsuo
Keino, Hiroshi
El-Salhy, Magdy
Ozaki, Michitaka
Umezawa, Kazuo
CELLS, 2021, 10 (09)
[48] Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-κB inhibitor
Takatsuna, H
Morita, S
Nagatsu, T
Sawada, M
Umezawa, K
BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (06) : 318 - 322
[49] A novel association between filamin A and NF-κB inducing kinase couples CD28 to inhibitor of NF-κB kinase α and NF-κB activation
Muscolini, Michela
Sajeva, Angela
Caristi, Silvana
Tuosto, Loretta
IMMUNOLOGY LETTERS, 2011, 136 (02) : 203 - 212
[50] IκBα independent induction of NF-κB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells
Watanabe, Mariko
Dewan, Md Zahidunnabi
Taira, Miyako
Shoda, Momoko
Honda, Mitsuo
Sata, Testutaro
Higashihara, Masaaki
Kadin, Marshall E.
Watanabe, Toshiki
Yamamoto, Naoki
Umezawa, Kazuo
Horie, Ryouichi
LABORATORY INVESTIGATION, 2007, 87 (04) : 372 - 382

← 1 2 3 4 5 →